| |
| |
|
| Insider
Information: |
Giuffre Randall Michael |
| Relationship: |
Director |
| City: |
Minneapolis |
| State: |
MN |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
364,551 |
|
|
Indirect Shares
|
46,643 |
|
|
| Direct
Value |
$922,314 |
|
|
|
Indirect Value
|
$118,007 |
|
|
| Total
Shares |
411,194 |
|
|
| Total
Value |
$1,040,321 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
10
|
0
|
|
Stock
price went up :
|
8
|
0
|
| Stock
price went down : |
2
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
4.0
|
0.0
|
| Percentage
Gain/Loss : |
 93.1%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Diamedica Therapeutics Inc. |
DMAC |
Director |
2024-01-02 |
364,551 |
2024-01-02 |
46,643 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
16 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| DMAC |
Diamedica Therapeutics In... |
Director |
– • – |
2024-01-02 |
4 |
A |
$2.80 |
$53,749 |
D/D |
19,196 |
364,551 |
0 |
- |
|
| DMAC |
Diamedica Therapeutics In... |
Director |
– • – |
2023-06-23 |
4 |
GD |
$0.00 |
$0 |
D/D |
15,000 |
345,355 |
0 |
- |
|
| DMAC |
Diamedica Therapeutics In... |
Director |
– • – |
2023-06-23 |
4 |
B |
$3.91 |
$254,150 |
D/D |
65,000 |
360,355 |
2.39 |
% |
|
| DMAC |
Diamedica Therapeutics In... |
Director |
– • – |
2023-01-03 |
4 |
A |
$1.53 |
$53,749 |
D/D |
35,130 |
295,355 |
0 |
- |
|
| DMAC |
Diamedica Therapeutics In... |
Director |
– • – |
2022-12-09 |
4 |
B |
$1.43 |
$53,023 |
D/D |
37,079 |
260,225 |
2.39 |
% |
|
| DMAC |
Diamedica Therapeutics In... |
Director |
– • – |
2022-12-08 |
4 |
B |
$1.40 |
$28,000 |
D/D |
20,000 |
223,146 |
2.39 |
% |
|
| DMAC |
Diamedica Therapeutics In... |
Director |
– • – |
2022-12-07 |
4 |
B |
$1.40 |
$31,604 |
D/D |
22,574 |
203,146 |
2.39 |
% |
|
| DMAC |
Diamedica Therapeutics In... |
Director |
– • – |
2022-12-06 |
4 |
B |
$1.35 |
$3,105 |
D/D |
2,300 |
180,572 |
2.31 |
% |
|
| DMAC |
Diamedica Therapeutics In... |
Director |
– • – |
2022-12-01 |
4 |
B |
$1.19 |
$975 |
D/D |
819 |
178,272 |
2.31 |
% |
|
| DMAC |
Diamedica Therapeutics In... |
Director |
– • – |
2022-12-01 |
4 |
B |
$1.20 |
$55,360 |
D/D |
46,133 |
177,453 |
2.39 |
% |
|
| DMAC |
Diamedica Therapeutics In... |
Director |
– • – |
2022-11-30 |
4 |
B |
$1.19 |
$3,534 |
D/D |
2,970 |
131,320 |
2.31 |
% |
|
| DMAC |
Diamedica Therapeutics In... |
Director |
– • – |
2022-11-29 |
4 |
B |
$1.19 |
$21,569 |
D/D |
18,125 |
128,350 |
2.39 |
% |
|
| DMAC |
Diamedica Therapeutics In... |
Director |
– • – |
2022-01-03 |
4 |
A |
$3.58 |
$53,793 |
D/D |
15,026 |
110,225 |
0 |
- |
|
| DMAC |
Diamedica Therapeutics In... |
Director |
– • – |
2020-11-20 |
4 |
B |
$4.26 |
$63,912 |
D/D |
15,000 |
108,588 |
2.39 |
% |
|
| DMAC |
Diamedica Therapeutics In... |
Director |
– • – |
2020-06-01 |
4 |
A |
$4.59 |
$35,729 |
D/D |
7,784 |
93,588 |
0 |
- |
|
| DMAC |
Diamedica Therapeutics In... |
Director |
– • – |
2018-12-11 |
4 |
B |
$4.00 |
$45,000 |
D/D |
11,250 |
85,804 |
2.39 |
- |
|
16 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
